Nj State Employees Deferred Compensation Plan Puma Biotechnology, Inc. Transaction History

Nj State Employees Deferred Compensation Plan

$824 Million
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 24, 2019	SELL	$12.3 - $35.76 $86,100 - $250,320	-7,000 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$20.77 - $42.37 $62,310 - $127,109	-3,000 Reduced 30.0%	7,000 $271,000
Q1 2018 May 02, 2018	BUY	$59.7 - $99.25 $119,400 - $198,500	2,000 Added 25.0%	10,000 $680,000
Q4 2017 Feb 06, 2018	SELL	$93.85 - $132.45 $93,850 - $132,450	-1,000 Reduced 11.11%	8,000 $791,000
Q3 2017 Oct 30, 2017	BUY	$72.0 - $119.75 $648,000 - $1.08 Million	9,000	9,000 $1.08 Million

Others Institutions Holding PBYI

# of Institutions

101

Shares Held

29M

Call Options Held

50.6K

Put Options Held

16.3K

Vanguard Group Inc Valley Forge, PA

3.64M
Shares

$10 Million
0.0% of portfolio
Black Rock Inc. New York, NY

3.57M
Shares

$9.83 Million
0.0% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

3.06M
Shares

$8.42 Million
0.42% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

2.88M
Shares

$7.92 Million
0.0% of portfolio
Acadian Asset Management LLC Boston, MA

1.97M
Shares

$5.41 Million
0.02% of portfolio

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $125M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nj State Employees Deferred Compensation Plan, based on Form 13F filings with the SEC.

News

Stay updated on Nj State Employees Deferred Compensation Plan with notifications on news.

Account